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Introduction: We describe the results of 15 patients suffering from essential blepharospasm with apraxia of eyelid
opening who underwent frontalis suspension surgery.
Material and methods: Patients with apraxia of eyelid opening and unresponsive to botulinum toxin injections
were studied. Bilateral frontalis suspension surgery was performed (sling operation) using polytetrafluoroethylene
(Gore-Tex®) sutures. The patients reported the degree of improvement using a subjective rating scale to evaluate the
benefit of the operation at two times after surgery (0-10 days and 180-360 days).
Results: The patients reported a high degree of subjective improvement. In the early postoperative period (0-10 days)
the mean degree of subjective improvement was 74.6% (standard deviation (SD) 26.4%). At 180-360 days after surgery
the mean improvement was 70.0% (SD 26.7%). Small hematomas of the upper lid occurred postoperatively in all
patients. Other complications were suture extrusions (9.1%), suture granulomas (6.1%), lacrimation (5.0%) and local
infections (7.5%). Postoperatively, all patients needed additional botulinum toxin injections for optimal outcome.
Conclusion: Frontalis suspension surgery is a minimally invasive and effective treatment option for apraxia of eyelid
opening in patients with essential blepharospasm unresponsive to botulinum toxin injections alone.
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The treatment of essential blepharospasm with botulinum
toxin (BoNT) is a well-established method [1,2]. However,
some patients suffer from a special form of blepharospasm
that renders them unable to open their eyes adequately
despite local BoNT treatment. This phenomenon is due to
the inability to raise the eyelid (see Figure 1). This is re-
ferred to in the literature as “apraxia of eyelid opening”,
“levator inhibition blepharospasm” or “dystonic eyelid
opening disorder” [3-6]. It leads to a compensatory con-
strained posture such as retroflexion of the head to enable
the patient to see through the narrow palpebral fissure.
The patients frequently exhibit photophobia, and perform
certain compensatory movements to keep the palpebral
fissure as wide as possible. Many patients increase vertical* Correspondence: rlaskaw@gwdg.de
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article, unless otherwise stated.traction by contracting the frontalis muscle to widen the
opening of the palpebral fissure. Since BoNT treatment
alone will not provide any significant improvement of the
eye opening, a number of more or less invasive surgical
procedures have been introduced [3-5,7,8]. In our patients
with this condition we perform frontalis suspension
surgery (“sling operation”) based on the technique of
Roggenkämper and Nüssgens [3,4]. In this report we
describe this surgical procedure and present our re-
sults of the operation as well as the assessments of the
patients with regard to the success of the treatment
and to their quality of life.Patients and methods
General information
This retrospective analysis, which had the approval of our
institutional ethics review board (University of Göttingen
Medical Center), encompasses 15 patients, nine women
and six men, who underwent bilateral frontalis suspensionntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Figure 1 Clinical presentation and compensatory maneuvers
in patients with blepharospasm and apraxia of eyelid opening.
A: Patient with apraxia of eyelid opening. Retroflexion of the head.
B: Innervation of the frontalis muscle as a compensatory maneuver
to increase eye opening. C: Lifting the upper lid with a finger to
open the eye.
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the lid retractors. All patients had had preoperative BoNT
therapy, which by itself had not enabled adequate eyelid
opening. A total of 40 eyelid operations, including revi-
sions (number see below) were performed. Seven patients
were operated on in one session and eight in a two-stage
procedure. A total of ten surgical revisions of five eye-
lids were necessary in three patients. Thirty-six opera-
tions (90%) were performed in general anesthesia withintubation. The patients participated voluntarily in the
postoperative interviews (see below). Photographs of
patients are published with their written consent.
Surgical technique
All primary operations (based on [3,4], n = 30) were per-
formed in general anesthesia. The eyebrows and the eye-
lids were infiltrated subcutaneously with a local anesthetic
containing epinephrine (1% Ultracain®) to reduce local
bleeding. After disinfecting the skin (Braunol®), and
sketching the incision lines above the upper edge of the
lid and slightly above the eyebrow (Figure 2) we made
three skin incisions and locally undermined the skin so
that the polytetrafluoroethylene (PTFE, Gore-Tex®) su-
tures and knots used for the suspension could be buried
as deeply as possible (Figure 2). A lid plate was inserted
under the eyelid during the incision to protect the eye.
Depending on the thickness of the eyelid, a size 3-0 (87%)
or 4-0 (13%) suture was passed through the medial caudal
incision in the upper border of the eyelid cephalad to the
medial incision just above the eyebrow. A needle was used
to pass the suture subcutaneously (see Figure 2). On re-
traction, the needle was used to pull a second subcutane-
ous PTFE suture caudally through the medial incisions
(Figure 2). Starting from the medial incision, two loops
(squares) of rectangular shape were then formed with sub-
cutaneous PTFE sutures (medial, lateral, Figure 2). In
order to form an adequate angle, the sutures were led out
of the other incisions (lateral, medial) and then reinserted
subcutaneously in the desired direction. Finally, the ends
of each suture were brought out through the medial upper
incision for the first square and out of the lateral upper in-
cision for the second square to be tied (Figure 2). The sur-
gical site was disinfected after each step in placing the
sutures. The skin incisions, except for the lateral and med-
ial upper incisions above the eyebrow, were then closed
(Figure 2). The position of the eyelid was assessed and
adjusted to give a slight overcorrection with a discrete
2-3 mm wide palpebral fissure. The protruding sutures
were knotted and buried subcutaneously. The lateral
and medial upper incisions were then closed with skin
sutures. We used thin, absorbable sutures (Vicryl® 7-0)
for skin closure to avoid having to remove them later
(Figure 2). Ointment (Polyspectran®) was applied to the
eyes, and the forehead and upper eyelid were covered
with a sterile dressing.
Subjective evaluation of treatment success
Postoperative “satisfaction” with the operation was assessed
individually for each eye see [3,4]. The left and right side
were evaluated separately because the patients might
possibly register a difference, e.g. eye-opening not equally
good or bad on both sides, or because the eyes were oper-





Figure 2 Steps in frontalis suspension operation. A: Typical incisions in the upper eyelid and above the eyebrow. B: Subcutaneous insertion
of polytetrafluoroethylene (Gore-Tex®) sutures from the edge of the upper eyelid to the caudal portion of the frontalis muscle. C: The two sutures
are positioned to form the lateral and medial two loops (squares) of rectangular shape. D: Sutures brought out laterally and medially before tying
the knots. E: Final status with desired slight opening of the eyelid after tying and burying the knots and stitching the skin incisions. The final step
is to apply eye ointment and a special dressing that allows both eyes to be opened immediately after surgery. F: The subcutaneous position of
the polytetrafluoroethylene sutures is illustrated in an idealized manner. The arrows indicate the direction of force of the frontalis muscle. By
suspending the upper eyelid from the caudal frontalis muscle, the upper eyelid can be actively raised by the patient.
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at two different time windows. Success was scored on a
scale of zero to 100 percent. Zero percent was the “lack of
any improvement after the operation”, whereas 100% was
“optimal treatment results and resolution of all complaints
after the operation”. The assessment periods were be-
tween day 1 to 10 (early postoperative period) and be-
tween day 180 to 365 (late postoperative period) after
surgery. The percentage values for the left and the right
eye were added for each patient, and the average and
standard deviation (SD) were calculated. The average
group value of each time period was obtained by calculat-
ing the average and standard deviation of the individual
averages during that period.
Thirteen patients were able to assess the results in both
time periods, while two patients were only able to assess
the first period, since the required interval for the second
period had not elapsed since the operation.
Results
General information
The average interval between the first manifestation of
the disorder and the diagnosis was 2.9 years (SD 1.9 years;
range 0 to 7.0 years). The average interval between initial
diagnosis and begin of BoNT therapy was 0.73 years (SD
1.78; range 0 to 7.0 years).
The average interval between starting local BoNT
treatment and the first frontalis suspension operation
was 2.8 years (SD 1.7 years; range 1.0 to 6.0 years).Surgical technique and complication rate
All patients initially reported an improvement of their
symptoms (see example in Figure 3). No major complica-
tions occurred during surgery or in the immediate postop-
erative period. The typical and unavoidable postoperative
local hematomas and discrete edema of the upper lid were
seen in all patients. The relevant postoperative events are
summarized in Table 1. During the study period, including
revision operations, a total of 66 PTFE sutures or loops
(squares) of rectangular shape were placed in the fifteen
patients. Six sutures had to be removed during this period
because of local tissue reaction giving an extrusion rate of
9.1% (see Table 1). The interval between surgery and reac-
tion to the suture or to revision surgery was two weeks to
five months (mean 2.6 months; SD 1.98 months).
BoNT treatment was continued in all patients, since the
effect of the operation alone, although it greatly improved
the situation, was not sufficient for an optimal result.
Individual observations
Several interesting details became apparent when the re-
sults of the individual patients who had undergone the
frontalis suspension procedure were analyzed. These are
presented in two short case reports.
Case 1
A 56-year old female patient underwent bilateral two-
stage frontalis suspension surgery for typical blepharo-
spasm with apraxia of eyelid opening (Figure 3). After
Figure 3 Patient after bilateral frontalis suspension surgery. The eyes can be opened (A) and closed (B) without difficulty. The patient’s
BoNT treatment was continued. Insert C shows the situation immediately after the unilateral operation of the left eye, identifiable by the small
hematoma. One can clearly see that the apraxia persists in the non-operated right eye and that eye opening is not possible in spite of innervation
of the frontalis muscle. The position of the eyebrow is higher and the upper eyelid is completely closed. After the suspension surgery, the left,
operated eye is already partly opened with only a low-intensity innervation. This is consistent with a lateralized control of the apraxia.
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effect appeared to differ between the two sides (Figure 3).
When the patient attempted to raise her eyebrows we ob-
served an increased innervation of the frontalis muscle on
the non-operated side but without a resulting adequate lift
of the eyelid. A markedly slighter innervation of the fron-
talis muscle of the treated side gave a much wider opening
of the eyelid (Figure 3).
Case 2
A 73-year old male patient with multifocal dystonia pre-
sented with blepharospasm and apraxia of eyelid opening.
Following successful frontalis suspension surgery the PTFE
sutures were expulsed on both sides after two months
(right side), respectively five months (left side). Despite re-
peated revision operations with the aim of burying the
knots the sutures eventually had to be removed. Despite
this the patient continued to be able to open his eyes.Table 1 Type and incidence of postoperative
complications
Postoperative complications Frequency
Suture extrusion 6 of 66 sutures (9.1%)
Suture granuloma 4 of 66 sutures (6.1%)
Lacrimation 2 of 40 operated eyelids (5.0%)
Infection 3 of 40 operated eyelids (7.5%)The effect persisted for seven months (right eye), re-
spectively 11 months (left eye).
Subjective rating of success of treatment
All of the fifteen patients reported an initial postopera-
tive improvement of eye opening.
The average early postoperative (0 to 10 days) subjective
rating of therapeutic success was 74.6% (SD 26.4%; range
20 to 100%). The average rating at the later period (180 to
365 days) was 70.0% (SD 26.7%; range 0 to 100%).
Discussion
One main approach in the treatment of essential
blepharospasm is to reduce muscle mass in the cranial
portion of the orbicularis oculi muscle, often together
with parts of the procerus and the corrugator supercilii
muscles [7]. These procedures can be combined with
suspension operations [8]. They are considerably more
invasive than suspension operations alone, as performed
in our own and other institutions [3-5].
The polytetrafluoroethylene (PTFE, Gore-Tex®) sutures
gave satisfactory functional results. However, it is well
known that PTFE sutures do not always integrate well
into the tissue bed, and they can cause problems with
tissue reactions and extrusion [9-11]. The extrusion rate
of 9.1% and the 6.1% incidence of granulomas in our pa-
tients are similar to those described by other authors [5].
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introduced using our method is extruded, a new one can
be inserted without any problems after a waiting period
of only a few weeks. In addition, if the traction effect of
the suture decreases, it is possible to uncover the knot
and “reposition” the upper eyelid.
Fascia lata gives very good functional results compared
to other materials [12,13], but we prefer polytetrafluoro-
ethylene because this is a minimally invasive option to
elevate the upper lid in patients with blepharospam with
apraxia of eye lid opening. The removal of fascia lata is
more invasive, an additional skin incision is needed in
another body region (thigh), and the results do not differ
much from the use of polytetrafluoroethylene in this
connection [12,13].
Our observations in individual patients were interest-
ing. In our surgically treated patients, we did not observe
the known effect that a unilateral BoNT injection can
cause bilateral improvement of blepharospasm. The
observed phenomenon of a lateralized change in the
ability to raise the eyelid is an argument for a lateralized
“organization” of the apraxia of eyelid opening. Another
observation was that adequate eye opening could persist
even after a suture had to be removed. This phenomenon
has not been described previously in the literature. In the
case described here, a new suture was implanted in a dif-
ferent position after an appropriate waiting period. The
observed phenomenon could be due to the development
of filiform scar tissue that, for a limited time, could still
give traction on the upper eyelid when the frontalis
muscle contracted. This could also be an effect of the
remaining sutures if not all had been removed. In this
case, the remaining sutures maintain a connection be-
tween the upper eyelid and the caudal part of the frontalis
muscle.
All patients had preoperative BoNT therapy, but this
alone was unable to allow sufficient elevation of the eye-
lids. The patients rated the treatment results as an im-
provement, which underscores the positive effect of the
operation. It was not possible to discontinue BoNT
treatment in any of the patients, since alleviation of the
orbicularis oculi muscles spasms appears to be in vary-
ing degrees an essential component for optimal results.
It is relevant in this context that the BoNT injections
during postoperative treatment should not be placed in
the caudal portion of the frontalis muscle. This is very
important since the strength of the frontalis muscle and
the ability to raise the upper eyelid would be reduced if
this recommendation were to be ignored. The study by
Grivet et al. [14] is of interest in this context. The au-
thors reported that the immediate postoperative im-
provement of the “Functional Disability Scores” (FDS)
was significantly greater in those patients with bleph-
arospasm whose BoNT treatment had been discontinuedpostoperatively compared to those whose treatment had
not been interrupted. But the FDS of the patients with
postoperatively continued BoNT injections improved
later to the level of the patients without postoperative
BoNT treatment. In their analysis, however, the authors
did not stratify their patients by subtypes or by surgical
method. If such a total absence of spasms of the orbicu-
laris oculi muscle is basically relevant in patients with
apraxia of eyelid opening remains undecided. Our data,
which show that continuing postoperative BoNT treat-
ment was necessary in all patients, argue against that
assumption.
The average subjective improvement ratings of our pa-
tients were between 75% and 70%, which is a relatively
high level see [3-5]. Roggenkämper and Nüssgens [3,4] ob-
served a stable effect for their patient population as a
whole, a result that is similar to the analysis of the follow-
up period of our study. But this retrospective study does
have some limitations. The results would have been more
robust had the improvement of eye opening described by
the patients been confirmed by objective measurements.
A validated questionnaire and score for the patients’ self-
assessment with focus on the degree of eye opening would
also have been useful. A further study with a greater num-
ber of patients would be useful more detailed insights into
this rare and complex disease and determine the therapy
options.
In summary one can conclude that frontalis suspension
surgery using polytetrafluoroethylene (Gore-Tex®) sutures
is a minimally invasive and effective option for the treat-
ment of apraxia of eyelid opening in patients with essen-
tial blepharospasm. The quality of daily life and general
patient satisfaction is improved. The combination with
botulinum toxin injections seems to be of advantage for
an optimal treatment outcome.Competing interests
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